Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease leukemia
Phenotype C0001815|myelofibrosis
Sentences 7
PubMedID- 24307514 Thalidomide treatment in a myelofibrosis patient with leukemia transformation.
PubMedID- 25148222 Depletion of stat5 blocks tel-syk-induced apmf-type leukemia with myelofibrosis and myelodysplasia in mice.
PubMedID- 23628022 The pathological characteristics of 29 leukemia patients with secondary myelofibrosis were observed, the degree of hyperplasia between bone marrow smear and biopsy, as well as the changes of myelofibrosis after treatment were compared, and their relationship with the prognosis was analysed.
PubMedID- 22379292 Coexistence of chronic lymphocytic leukemia (cll) with myelofibrosis is a rare association with only isolated case reports in the literature.
PubMedID- 22075327 Immunohistochemistry staining (leukocyte phenotyping kit, sun biotech, china) of these cells revealed a total of 55% positivity for cd41 (figure 1c) and 60% positivity for cd42b (figure 1d), while cd13, cd14, cd68, mpo, hla-dr, cd10, cd19, cd3, cd5, and cd7 were all negative a bone marrow biopsy indicated acute leukemia with myelofibrosis (figure 1e &1f).
PubMedID- 24201159 Transformed acute myeloid leukemia in myelofibrosis results in a median survival of less than 5 months.
PubMedID- 22386731 Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.

Page: 1